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SYMPTOMATIC HYPERPERFUSION AFTER SURGICAL REVASCULARIZATION 
FOR MOYAMOYA DISEASE: INCIDENCE, NATURAL HISTORY AND PREDICTORS 
Tsang Chun Pong, Ho Wai Shing Wilson, Leung Ka Kit Gilberto, Lui Wai Man 
 
Department of Neurosurgery, Queen Mary Hospital 
 
AIM: To study the incidence, natural history and predictors for post-revascularization 
symptomatic hyperperfusion in moyamoya patient. 
 
BACKGROUND: Moyamoya disease is an uncommon cerebrovascular disease. It refers to 
progressive stenosis of the internal carotid artery at supraclinoid level, resulted into cerebral 
ischemia. Direct and/or indirect revascularizations are well established procedures to improve 
cerebral perfusion and decrease the risk of future stroke in patients with moyamoya disease. Peri-
operative ischemic stroke is one of the major complications. Transient neurological events may 
occur other than that. 
 
METHOD: Patients with moyamoya disease undergone revascularization operation were 
included. All the medical records were studied retrospectively. Symptomatic hyperperfusion was 
defined as new neurological event with improved perfusion on perfusion scan. 
 
RESULTS: From January 2009 to February 2015, 16 patients with moyamoya disease had 
undergone 22 revascularization operations. The mean age was 38.9 years old. 15 of them 
presented with ischemic symptoms. The mean follow-up was 16 months. All grafts of direct 
revascularization were patent on post-operative computed tomographic angiogram. Two patients 
(9%) had persistent/ recurrent ischemic symptoms after the operation. 9 operated hemisphere 
(40%) were found to have symptomatic hyperperfusion. The mean onset interval from operation 
was 4 days. All were transient with complete resolution of symptoms. No significant predictor 
was identified, including the presence of pre-existing extracranial-intracranial anastomosis and 
the proximity of the recipient vessel. 
 
SUMMARY: New neurological event after revascularization operation for moyamoya disease 
could be ischemic or hyperperfusion related. Symptomatic hyperperfusion was not uncommon in 
our series. All patients improved with time. 
